Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis

Oncogene

Volumn 25, Issue 29, 2006, Pages 4056-4066

  Jiang, M ^a   Wei, Q ^a   Wang, J ^a   Du, Q ^a   Yu, J ^b   Zhang, L ^b   Dong, Z ^a,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cisplatin; Mitochondria; Nephrotoxicity; p53; PUMA

Indexed keywords

CISPLATIN; CYTOCHROME C; PIFITHRIN ALPHA; PROTEIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; PUMA ALPHA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; IN VIVO STUDY; KIDNEY; KIDNEY CELL; MALE; MITOCHONDRION; MOLECULAR INTERACTION; MOLECULE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CELL LINE; CISPLATIN; CYTOCHROMES C; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 33745778238     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209440     Document Type: Article

References (52)

1. Adams JM, Cory S. (1998). Science 281: 1322-1326.
2. Akeshima R, Kigawa J, Takahashi M, Oishi T, Kanamori Y, Itamochi H et al. (2001). Br J Cancer 84: 1551-1555.
3. Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. (2004). Am J Physiol Renal Physiol 287: F543-F549.
4. Arany I, Safirstein RL. (2003). Semin Nephrol 23: 460-464.
5. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. (1998). Kidney Int 53: 394-401.
6. Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L, Lin C. (2005). Life Sci 76: 1883-1893.
7. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. (2001). Mol Cell 8: 705-711.
8. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. (2005). Science 309: 1732-1735.
9. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. (2004). Science 303: 1010-1014.
10. Cummings BS, Schnellmann RG. (2002). J Pharmacol Exp Ther 302: 8-17.
11. Danial NN, Korsmeyer SJ. (2004). Cell 116: 205-219.
12. Dong Z, Wang J. (2004). J Biol Chem 279: 9215-9221.
13. Dong Z, Wang JZ, Yu F, Venkatachalam MA. (2003). Am J Pathol 163: 663-671.
14. Fuertesa MA, Castillab J, Alonsoa C, Perez JM. (2003). Curr Med Chem 10: 257-266.
15. Gottlieb RA, Granville DJ. (2002). Methods 26: 341-347.
16. Green DR, Kroemer G. (2004). Science 305: 626-629.
17. Gudkov AV, Komarova EA. (2005). Biochem Biophys Res Commun 331: 726-736.
18. Hsu YT, Youle RJ. (1998). J Biol Chem 273: 10777-10783.
19. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. (2003). Cancer Cell 4: 321-328.
20. Jiang M, Yi X, Hsu S, Wang CY, Dong Z. (2004). Am J Physiol Renal Physiol 287: F1140-F1147.
21. Kaushal GP, Kaushal V, Hong X, Shah SV. (2001). Kidney Int 60: 1726-1736.
22. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. (1999). Science 285: 1733-1737.
23. Li S, Basnakian A, Bhatt R, Megyesi J, Gokden N, Shah SV et al. (2004). Am J Physiol Renal Physiol 287: F990-F998.
24. Liu H, Baliga R. (2003). Kidney Int 63: 1687-1696.
25. Martinou JC, Green DR. (2001). Nat Rev Mol Cell Biol 2: 63-67.
26. Megyesi J, Safirstein RL, Price PM. (1998). J Clin Invest 101: 777-782.
27. Miyashita T, Reed JC. (1995). Cell 80: 293-299.
28. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. (1998). Proc Natl Acad Sci USA 95: 5724-5729.
29. Nakano K, Vousden KH. (2001). Mol Cell 7: 683-694.
30. Niedner H, Christen R, Lin X, Kondo A, Howell SB. (2001). Mol Pharmacol 60: 1153-1160.
31. Nowak G. (2002). J Biol Chem 277: 43377-43388.
32. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Science 288: 1053-1058.
33. Park MS, De Leon M, Devarajan P. (2002). J Am Soc Nephrol 13: 858-865.
34. Ramesh G, Reeves WB. (2002). J Clin Invest 110: 835-842.
35. Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. (2002). Nat Cell Biol 4: 842-849.
36. Sheikh-Hamad D, Cacini W, Buckley AR, Isaac J, Truong LD, Tsao CC et al. (2004). Arch Toxicol 78: 147-155.
37. Shen ZN, Nishida K, Doi H, Oohashi T, Hirohata S, Ozaki T et al. (2005). Biochem Biophys Res Commun 328: 375-382.
38. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K et al. (2000). Am J Physiol Renal Physiol 278: F726-F736.
39. Siddik ZH. (2003). Oncogene 22: 7265-7279.
40. Tomasoni S, Benigni A. (2004). Curr Gene Ther 4: 115-122.
41. Tomita N, Azuma H, Kaneda Y, Ogihara T, Morishita R. (2004). Curr Drug Targets 5: 717-733.
42. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M et al. (2003). Kidney Int 63: 72-82.
43. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. (2003). Science 302: 1036-1038.
44. Vousden KH, Lu X. (2002). Nat Rev Cancer 2: 594-604.
45. Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z. (2004). J Biol Chem 279: 19948-19954.
46. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Science 292: 727-730.
47. Wei Q, Wang MH, Dong Z. (2005). Am J Nephrol 25: 491-499.
48. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG et al. (1996). Kidney Int 50: 125-134.
49. Yi X, Yin XM, Dong Z. (2003). J Biol Chem 278: 16992-16999.
50. Yu F, Megyesi J, Safirstein RL, Price PM. (2005). Am J Physiol Renal Physiol 289: F514-F520.
51. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. (2003). Proc Natl Acad Sci USA 100: 1931-1936.
52. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. (2001). Mol Cell 7: 673-682.